S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Cumberland Pharmaceuticals Inc

CPIX XNAS
$3.79 +0.76 (+24.75%) ▲ 15-min delayed
Open
$5.71
High
$6.04
Low
$3.66
Volume
49.54M
Market Cap
$45.62M

About Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 93 Website →

Key Financials

Period Revenue Net Income EPS
TTM 2025 $44.52M $-2,864,711 $-0.19
FY 2025 $44.52M $-2,864,711 $-0.19
Q3 2025 $8.29M $-1,949,046 $-0.13
Q2 2025 $10.84M $-735,207 $-0.05

Get CPIX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cumberland Pharmaceuticals Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.